Kumar Shiva Gubbiyappa

Dr. Kumar Shiva Gubbiyappa

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2014 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
GGGaurav Gupta
Gaurav Gupta
GKGopala Krishna
Gopala Krishna
DCDinesh Kumar Chellappan
Dinesh Kumar Chellappan
KGKumar Shiva Gubbiyappa
Kumar Shiva Gubbiyappa
MCMayuren Candasamy
Mayuren Candasamy
Kamal DuaKamal Dua
Kamal Dua

10 October 2019 in BioFactors
Verified
Journal Article
Closed access
PDF file
YJYujiang Ji
Yujiang Ji
SNSanatkumar B. Nyamagoud
Sanatkumar B. Nyamagoud
Nagaraja SreeharshaNagaraja Sreeharsha
Nagaraja Sreeharsha
AMAnurag Mishra
Anurag Mishra
KGKumar Shiva Gubbiyappa
Kumar Shiva Gubbiyappa
YSYogendra Singh
Yogendra Singh

26 July 2019 in Biotechnology and Applied Biochemistry
Verified
Journal Article
Closed access
YSYogendra Singh
Yogendra Singh
VSVijaya Paul Samuel
Vijaya Paul Samuel
SDSunita Dahiya
Sunita Dahiya
GGGaurav Gupta
Gaurav Gupta
RGRitu Gillhotra
Ritu Gillhotra
Kamal DuaKamal Dua
Kamal Dua

29 November 2020 in Molecules
Verified
Journal Article
Open access
PDF file
PSPredeepkumar Narayanappa Shiroorkar
Predeepkumar Narayanappa Shiroorkar
Obaid AfzalObaid Afzal
Obaid Afzal
IKImran Kazmi
Imran Kazmi
FAFahad A. Al-Abbasi
Fahad A. Al-Abbasi
AAAbdulmalik Saleh Alfawaz Altamimi
Abdulmalik Saleh Alfawaz Altamimi
Nagaraja SreeharshaNagaraja Sreeharsha
Nagaraja Sreeharsha
Sepsis aggregates undesirable immune response causing depression of ventricular myocardium and diastolic dysfunction. This present study examined the effect of a plant-derived flavone tangeretin (TG) on autophagy and reduction in myocardial dysfunction. The sepsis was induced by cecum ligation and puncture (CLP) in male Sprague–Dawley rats. Abnormal changes were seen in the heart after the sepsis induction. These abnormalities were analyzed based on the cardiac markers, namely Cardiac myosin light chain-1 (cMLC1) and Cardiac troponin I (cTnl), echocardiography, and plasma parameters, like Lactate dehydrogenase (LDH) and Creatinine kinase (CK). Microanatomy of the heart was studied using hematoxylin and eosin stained histopathological samples of cardiac tissue. Western blot technique was used to detect the nature and extent of protein with the amount of a specific RNA (gene expression) in the cardiac homogenate. Oxidative damage was analyzed using redox marker, reduced glutathione. This study successfully showed that TG attenuated sepsis-induced myocardial dysfunction by inhibiting myocardial autophagy via silencing the Phosphatase and tensin homolog (PTEN) expression and acting on the AKT/mTOR pathway. The present findings supported that TG is a novel cardioprotective therapeutic target for sepsis induced myocardial dysfunction.

18 April 2019 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
SSSushil Kumar Sah
Sushil Kumar Sah
VSVijaya Paul Samuel
Vijaya Paul Samuel
SDSunita Dahiya
Sunita Dahiya
YSYogendar Singh
Yogendar Singh
RGRitu M. Gilhotra
Ritu M. Gilhotra
Kamal DuaKamal Dua
Kamal Dua

7 November 2024 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
MAMantravadi Anusha
Mantravadi Anusha
KGKumar Shiva Gubbiyappa
Kumar Shiva Gubbiyappa
Objective: A unique liquid chromatography-mass spectrometry technique is essential for determining the concentration of asciminib in biological matrices, and its development is of the utmost importance. Methods: The samples that were processed were separated using a Reversed Phase-Phenomenex (100 mm x 4.6 mm, 5 µm) C18 analytical column. The column was equipped with an isocratic moveable phase that consisted of 0.1% (v/v) HCOOH and acetonitrile at a ratio of 18:82% (v/v). The flow rate of the phase was 0.70 ml/min. For asciminib, the multiple reaction monitoring mode was used at m/z 450.23/257.3, while for canagliflozin, it was used at m/z 445.13/267.31. Results: With a correlation coefficient of 0.9998, the method was linear for asciminib throughout the concentration range of 1.0-2100.00 ng/ml. Each day's accuracy percentage relative standard deviation was within 5.74%. For analytes at the low-quality control level, the mean matrix factors ranged from 96.34 to 104.85% with a % Coefficient of Variance (CV) of 4.21; at the high-quality control level, the range was from 94.62 to 103.88% with a %CV of 3.67. Conclusion: The method that has been developed has the potential to be used to examine the pharmacokinetics and toxicokinetics of asciminib in various biological samples for both forensic and clinical purposes.